Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

Dovetail issued patent for Betathine

Aug. 28, 1997

No Comments

Malignant melanoma indication approved for Intron A in U.K.

Aug. 27, 1997

No Comments

Theratope vaccine advances to phase III trials

Aug. 21, 1997

No Comments

Novopharm Biotech antibodies poised to enter phase I

Aug. 19, 1997

No Comments

NeoRx and Janssen enter agreement for Avicidin

Aug. 14, 1997

No Comments

ImClone Systems earns manufacturing milestone from Merck KGaA

Aug. 4, 1997

No Comments

GnRH conjugate vaccines prepared at Merck & Co.

July 30, 1997

No Comments

FDA advisory committee recommends approval of rituximab

July 28, 1997

No Comments

Bristol-Myers Squibb licenses cancer vaccines from Progenics

July 18, 1997

No Comments

Low-dose interferon alfa nears phase III for the treatment of Sjogren's syndrome

July 17, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Immuno-oncology, BioWorld Science
RSS

Dovetail issued patent for Betathine

Malignant melanoma indication approved for Intron A in U.K.

Theratope vaccine advances to phase III trials

Novopharm Biotech antibodies poised to enter phase I

NeoRx and Janssen enter agreement for Avicidin

ImClone Systems earns manufacturing milestone from Merck KGaA

GnRH conjugate vaccines prepared at Merck & Co.

FDA advisory committee recommends approval of rituximab

Bristol-Myers Squibb licenses cancer vaccines from Progenics

Low-dose interferon alfa nears phase III for the treatment of Sjogren's syndrome

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Experimental mRNA gene therapy suppresses preeclampsia in mice

Probing bidirectional cancer-autoimmune link can yield new targets

Immuno-oncology, BioWorld Science RSS

Immuno-oncology, BioWorld Science
RSS